Professor Maria Kavallaris
Chief Investigator, Education Committee Chair
University of New South Wales


Maria is head of the Tumour Biology and Targeting Program at Children’s Cancer Institute, Lowy Cancer Research Centre and co-Director of the Australian Centre for NanoMedicine.

Maria’s research focuses on identifying the mechanisms of action and resistance to anticancer drugs, discovering new protein interactions in cancer and the development of less toxic cancer therapies using nanotechnology.

Signature Projects

Professor Kavallaris is currently actively investigating within the following Signature Projects:

Featured Publications

Publication Year Authors
A Rationally Optimized Nanoparticle System for the Delivery of RNA Interference Therapeutics into Pancreatic Tumors in Vivo 2016 Teo, J.; McCarroll, J. A.; Boyer, C.; Youkhana, J.; Sagnella, S. M.; Duong, H. T. T.; Liu, J.; Sharbeen, G.; Goldstein, D.; Davis, T. P.; Kavallaris, M.; Phillips, P. A.
Analyses of Tumor Burden In Vivo and Metastasis Ex Vivo Using Luciferase-Expressing Cancer Cells in an Orthotopic Mouse Model of Neuroblastoma 2016 Byrne, F. L.; McCarroll, J. A.; Kavallaris, M.
Capping Group Choice in Tripeptide Hydrogels Influences Viability in the 3D Cell Culture of Tumor Spheroids 2016 Wojciechowski, J. P.; Martin, A. D.; Mason, A. F.; Fife, C. M.; Sagnella, S. M.; Kavallaris, M.; Thordarson, P.
Delineating the Role of IV-Tubulins in Pancreatic Cancer: βIV-Tubulin Inhibition Sensitizes Pancreatic Cancer Cells to Vinca Alkaloids 2016 Sharbeen, G.; McCarroll, J.; Liu, J.; Youkhana, J.; Limbri, L. F.; Biankin, A. V.; Johns, A.; Kavallaris, M.; Goldstein, D.; Phillips, P. A.
βIII-Tubulin: A novel mediator of chemoresistance and metastases in pancreatic cancer 2015 McCarroll, J.A., Sharbeen, G., Liu, J., Youkhana, J., Goldstein, D., McCarthy, N., Limbri, L.F., Dischl, D., Ceyhan, G.O., Erkan, M., Johns, A.L., Biankin, A.V., Kavallaris, M., Phillips, P.A.